Funding Received
$989.2 Thousand in 1 Round from 2 Investors
Most Recent Funding
$989.2 Thousand on January 20, 2010 / Undisclosed Round
Headquarters:
Eßlingen
Description:
Amedrix develops solutions based on native collagen medical devices for the regeneration of soft tissue defects.
Categories:
Biotechnology
Website:
http://www.amedrix.de

Company Details

Update

The Amedrix GmbH develops solutions based on native collagen medical devices for the regeneration of soft tissue defects, eg for the regeneration of skin defects. The matrices are used as three-dimensional cell carrier materials in the body's own cells migrate, proliferate and regenerate the defective tissue. A biopsy on the patient in advance is no longer necessary. Among the products are collagen solutions, gels, membrane, sponges and fleeces in the form, size and thickness are so variable that a wide range of defect is standard treatment possible. Collagen nukleinsäurefrei this is made with a specially developed process.

Funding Rounds (1) - $989.2k

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    Life Science Center Esslingen

    Schelztorstraße 54-56

    Eßlingen, 73728

    DEU

Images (1)

Update
  • 6c29cc488c93a2383649e66a74fa8a97